Felis ISSN 2398-2950

Glucosamine

Introduction

Name

  • Glucosamine.

Class of drug

  • Nutraceutical.
  • Amino acid.
  • Chondroprotective agent.

Description

Chemical name

  • Glucosamine.

Storage requirements

  • Store in a dry place <25°C.
  • Keep container tightly closed.

Uses

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Indications

  • A nutritional aid in the management of degenerative joint disease.
  • Mild anti-inflammatory effect.

Administration

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Pharmocokinetics

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Adverse Reactions

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Further Reading

Publications

Refereed papers

  • Recent references from PubMed.
  • Davis K T, Lunn K F (2011)Serum fructosamine in cats receiving an oral chondroprotective agent.Intern J Appl Res Vet Med9(1), 52-57/
  • McNamara P S, Barr S C, Erb H N & Barlow L L (2000)Hematologic, hemostatic and biochemical effects in cats receiving an oral chondroprotective agent for thirty days.Vet Therapeutics1(2), 108-117PubMed.
  • Canapp S O, McLaughlin R M, Hoskinson J J , Roush J K & Butine M D(2000)Scintigraphic evaluation of glucosamine HCl and chondroitin sulfate as treatment for acute synovitis in dogs.Am J Vet Res60(12), 1552-1557PubMed.
  • Anderson M A (1999)Oral chondroprotective agents. Part II. Evaluation of products.Comp Contin Ed Pract Vet21(9), 861-865.
  • Boothe D M (1998)Nutraceuticals in veterinary medicine. Part II. Safety and efficacy.Comp Contin Educ Pract Vet20(1), 15-21.
  • Hulse D A (1998)Treatment methods for pain in the osteoarthritic patient.Vet Clin North Am Small Anim Pract28(2), 361.
  • Boothe D M (1997)Nutraceuticals in veterinary medicine. Part I. Definitions and regulations.Comp Contin Educ Pract Vet19(12), 1248-1255.
  • Hanson R R, Smalley L R, Huff G K, White S & Hammad T A (1997)Oral treatment with a glucosamine-chondroitin sulfate compound for degenerative joint disease in horses - 25 cases.Equine Pract19(9), 16-22.
  • Morreale P (1996)Comparison of the anti-inflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis.J Rheumatol23, 1385-1391.

Other sources of information

  • McIlwraith C W (1999)Should I recommend the use of oral glycosaminoglycans?Comp Contin Educ Pract Vet21(5), 450, 457.

ADDED